Pål Lundin is currently the Director of Early Clinical Research at AstraZeneca, where they lead clinical teams and develop strategies for inflammatory bowel disease. With over 25 years of experience as a senior early clinical scientist and project director, Pål is recognized for their expertise in clinical trial design and their ability to mentor new team members while collaborating with external experts. Additionally, Pål serves as a Reserve Officer with the rank of Captain in Försvarsmakten.
This person is not in the org chart
This person is not in any teams
This person is not in any offices